Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores:

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores:

Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores:

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores:

Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores:

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models por Elizabeth R. Tucker (15053624)

Outros autores: